secwatch.observer — SEC 8-K summary
======================================

Issuer:     Odyssey Health, Inc. (ODYY)
CIK:        0001626644
Form:       8-K
Filed at:   2023-12-07T23:59:59+00:00
Accession:  0001683168-23-008697
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Odyssey Health shareholders approve asset sale of neurological drug therapies to Oragenics
--------------------------------------------------------------------------------

- Approved asset purchase agreement of neurological drug therapies and technologies to Oragenics, Inc.
- Vote: 45,032,700 for, 333,249 against, 48,943 abstaining on the asset purchase agreement.
- Approved adjournment proposal: 44,826,263 for, 255,690 against, 332,939 abstaining.
- Special meeting held on December 7, 2023; results filed via 8-K Item 5.07.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1626644/000168316823008697/0001683168-23-008697-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1626644/000168316823008697/odyssey_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-23-008697

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer